Harmony Biosciences
private biosimilars company
Based in PA
AI Overview
With $700K in lobbying spend across 15 quarterly filings, Harmony Biosciences is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2020 to 2023.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $50K |
| 2021 | $200K |
| 2022 | $200K |
| 2023 | $250K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Harmony Biosciences disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Taxation
Issues related to the development of therapies for rare diseases.
Issues related to the development of therapies for rare diseases
Issues regarding drug pricing.
Issues related to the development of therapies for rare diseases.
Issues regarding drug pricing.
H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
Issues related to the orphan drug tax credit.
Build Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 a
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.